Predicting quality of life during lung cancer immunotherapy
Part of Cancer, Lungs & breathing clinical trials.
This study uses a computer program (machine learning) to predict how lung cancer immunotherapy affects your quality of life. It aims to help doctors better support you during treatment by identifying problems early.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a lung cancer diagnosis confirmed by a biopsy (tissue sample).
- You are 18 years old or older.
- You are currently getting immunotherapy (treatment that helps your immune system attack cancer).
- You can talk and understand well enough to share your feelings and experiences.
- You (or a family member) must agree to participate by signing a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how patients with advanced lung cancer feel during their treatment, which combines chemotherapy, radiation, and an immunotherapy drug. The goal is to understand and improve quality of life during therapy.
This study aims to understand the care needs of people with lung cancer who are receiving or have received immunotherapy. By participating, you can help improve support for other patients going through similar treatment.
This trial tests a quality-of-life support program meant to help people with early-stage lung cancer think through their treatment choices. It may help you feel more informed and more confident about deciding between treatments like surgery and SBRT.
This study tests a smartphone-based program to help people with lung cancer manage symptoms at home while they receive combination drug therapy. It aims to see if this program is practical and helpful for patients, possibly improving their daily well-being during treatment.
This study looks at using blood and imaging markers to predict if patients with lung cancer who receive both immunotherapy and chest radiation will develop lung inflammation (called radiation lung injury). It may help doctors personalise care and reduce side effects.
This study uses artificial intelligence and CT scan analysis to predict how well lung cancer patients will respond to immunotherapy. It may help doctors choose the best treatment for you.
Hear when a new Lung Cancer Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.